{"schema_version":"secwatch.filing_event.v1","accession":"0001798749-23-000042","form_type":"8-K","ticker":"JBIO","cik":"0001798749","company_name":"Jade Biosciences, Inc.","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.643724+00:00","generated_at":"2026-06-14T05:10:00.594339+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Aerovate stockholders elect Dorval and Resnick as Class II directors; ratify KPMG as auditor","bullets":["Allison Dorval elected with 18,685,353 votes for and 366,333 withheld; Joshua Resnick elected with 18,169,764 for and 881,922 withheld.","Ratification of KPMG LLP as independent auditor for FY2023 passed with 21,184,481 votes for, 0 against, 201 abstain.","Meeting held June 6, 2023; no other matters voted on."],"urls":{"canonical":"https://secwatch.observer/filing/0001798749-23-000042","json":"https://secwatch.observer/filing/0001798749-23-000042.json","markdown":"https://secwatch.observer/filing/0001798749-23-000042.md","text":"https://secwatch.observer/filing/0001798749-23-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798749/000179874923000042/0001798749-23-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798749/000179874923000042/tmb-20230606x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:10:00.594339+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"54f0755bc3277a8d141df451d0f3f3027b35e10f","claim":"Jade Biosciences, Inc. shareholders approved Elect each of Allison Dorval and Joshua Resnick, M.D. as Class II directors at the 2023-06-06 meeting.","evidence_excerpt":"The Company’s stockholders approved the Class II director nominees recommended for election in Proposal 1 at the Annual Meeting. The results of Proposal 1 were as follows: Class II Director Nominee Votes For Votes Withheld Broker Non-Votes Allison Dorval 18,685,353 366,333 2,132,996 Joshua Resnick, M.D. 18,169,764 881,922 2,132,996","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1798749/000179874923000042/0001798749-23-000042-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-06"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}